Figure S2 from Camrelizumab Plus Gemcitabine, Vinorelbine, and Pegylated Liposomal Doxorubicin in Relapsed/Refractory Primary Mediastinal B-Cell Lymphoma: A Single-Arm, Open-Label, Phase II Trial

openalex(2023)

引用 0|浏览4
暂无评分
摘要
CT or PET-CT scans of all evaluated patients
更多
查看译文
关键词
lymphoma,liposomal doxorubicin,camrelizumab,b-cell,single-arm,open-label
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要